Metabolic Syndrome and Its Components in Psoriatic Arthritis
Author:
Open Access
- 1 February 2022
- journal article
- review article
- Published by Taylor & Francis in Open Access Rheumatology: Research and Reviews
- Vol. ume 14, 7-16
Abstract
Psoriatic arthritis (PsA) is a well-known inflammatory disorder with a wide variety of phenotypes that extend beyond the joints. It has been defined as an immune-mediated disorder in which Th-1 and Th-17 cells play a key role. It has been associated with an elevated risk of metabolic syndrome (MetS), which is characterized by abdominal obesity, hypertension, hyperglycemia, and hyperlipidemia. While the exact pathophysiology of the link between PsA and MetS has yet to be precisely determined, persistence of inflammatory abnormalities, with overexpression of pro-inflammatory cytokines, might be the cause. Studies have consistently emphasized the strong association between elevated risk of developing cardiovascular disease and MetS in individuals with underlying PsA. The literature has also shown an association between the increased PsA severity and the increased frequency of MetS components. This association has important clinical consequences when treating patients with PsA. Therefore, screening programs should be implemented for PsA patients to evaluate whether they have MetS, and appropriate treatment should be given to manage cardiometabolic risk factors. Patients should also be closely monitored for potential adverse treatment effects on co-morbidities. This article summarizes the evidence of associations between several components of MetS and PsA and analyzes the impact of treatment on these factors.Keywords
This publication has 96 references indexed in Scilit:
- Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patientsClinical Rheumatology, 2013
- The association between psoriasis and obesity: a systematic review and meta-analysis of observational studiesNutrition & Diabetes, 2012
- Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control studyClinical Rheumatology, 2011
- Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasisArthritis Care & Research, 2011
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritisArthritis Care & Research, 2011
- Increased Prevalence of the Metabolic Syndrome in Patients with Psoriatic ArthritisMetabolic Syndrome and Related Disorders, 2010
- IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T CellsThe Journal of Immunology, 2009
- Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP‐1 monocyte/macrophagesArthritis & Rheumatism, 2008
- Obesity alters gut microbial ecologyProceedings of the National Academy of Sciences of the United States of America, 2005